42 related articles for article (PubMed ID: 35298)
1. Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia.
Karpale M; Hukkanen J; Hakkola J
Cells; 2022 Jan; 11(3):. PubMed ID: 35159123
[TBL] [Abstract][Full Text] [Related]
2. PXR Suppresses PPARα-Dependent
Shizu R; Ezaki K; Sato T; Sugawara A; Hosaka T; Sasaki T; Yoshinari K
Cells; 2021 Dec; 10(12):. PubMed ID: 34944058
[TBL] [Abstract][Full Text] [Related]
3. Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines.
Chang TK
AAPS J; 2009 Sep; 11(3):590-601. PubMed ID: 19688601
[TBL] [Abstract][Full Text] [Related]
4. Drug interactions with St John's wort : mechanisms and clinical implications.
Mannel M
Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
[TBL] [Abstract][Full Text] [Related]
5. Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.
Galteau MM; Shamsa F
Eur J Clin Pharmacol; 2003 Dec; 59(10):713-33. PubMed ID: 14605790
[TBL] [Abstract][Full Text] [Related]
6. Digitoxin and its metabolites in patients with liver cirrhosis.
Nokhodian A; Santos SR; Kirch W
Eur J Drug Metab Pharmacokinet; 1993; 18(2):207-13. PubMed ID: 8243505
[TBL] [Abstract][Full Text] [Related]
7. Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver.
Luoma PV; Sotaniemi EA; Pelkonen RO; Arranto A; Ehnholm C
Eur J Clin Pharmacol; 1982; 23(3):275-82. PubMed ID: 7173298
[TBL] [Abstract][Full Text] [Related]
8. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of enzyme induction on antipyrine metabolite formation.
Danhof M; Verbeek RM; van Boxtel CJ; Boeijinga JK; Breimer DD
Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolism.
Kirch W; Spahn H; Kitteringham NR; Hutt HJ; Mutschler E; Ohnhaus EE
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):65S-68S. PubMed ID: 6743476
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects.
Perucca E; Ruprah M; Richens A; Park BK; Betteridge DJ; Hedges AM
Br J Clin Pharmacol; 1981 Oct; 12(4):592-6. PubMed ID: 6117310
[No Abstract] [Full Text] [Related]
12. Bioavailability and elimination of nitrendipine in liver disease.
Dylewicz P; Kirch W; Santos SR; Hutt HJ; Mönig H; Ohnhaus EE
Eur J Clin Pharmacol; 1987; 32(6):563-8. PubMed ID: 3653225
[TBL] [Abstract][Full Text] [Related]
13. Influence of nitrendipine and verapamil on plasma levels, urinary excretion, and beta-blocking effect of metoprolol.
Kirch W; Santos SR; Geller M; Mönig H; Stenzel J; Ohnhaus EE
Cardiovasc Drugs Ther; 1988 Jul; 2(2):205-9. PubMed ID: 3154706
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects.
Perucca E; Grimaldi R; Frigo GM; Sardi A; Mönig H; Ohnhaus EE
Eur J Clin Pharmacol; 1988; 34(6):595-9. PubMed ID: 2901960
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.
Kirch W; Rose I; Demers HG; Leopold G; Pabst J; Ohnhaus EE
Clin Pharmacokinet; 1987 Aug; 13(2):110-7. PubMed ID: 2887325
[TBL] [Abstract][Full Text] [Related]
16. A possible drug interaction between rifampicin and enalapril.
Kandiah D; Penny WJ; Fraser AG; Lewis MJ
Eur J Clin Pharmacol; 1988; 35(4):431-2. PubMed ID: 2848708
[TBL] [Abstract][Full Text] [Related]
17. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
Ohnhaus EE; Kirchhof B; Peheim E
Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
[No Abstract] [Full Text] [Related]
18. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
Ohnhaus EE; Park BK
Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
[No Abstract] [Full Text] [Related]
19. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.
Price DE; Mehta A; Park BK; Hay A; Feely MP
Br J Clin Pharmacol; 1986 Dec; 22(6):744-7. PubMed ID: 3567022
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
